Atlas Trials

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

Clinical trial NCT06843590 · RECRUITING

Trial details

NCT number
NCT06843590
Sponsor
Alkermes, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Hypersomnia
Start date
2025-05-22
Primary completion
2026-11-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.